Nan-Kai Wang is an expert in Ophthalmology at Columbia University Medical Center (United States). Nan-Kai Wang has authored 53 publications, the most recent in 2026. SLR score: 446 (community average: 125). How the SLR is computed.

LeadR Profile

Nan-Kai Wang Columbia University Medical Center United States
446 ScienceLeadR Reputation 446
Network Map

Ophthalmology

Subspecialties: Genetics - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Linkou Chang Gung Memorial Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 53

Citations

Citations: 203 1st author: 1 Last author: 18 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Combination therapy for myopia control using defocus incorporated multiple segments spectacles in children refractory to higher-dose atropine.
PMID 42891853 — ophthalmology, eyeglasses, therapeutics, myopia, atropine, child
Graefes Arch Clin Exp Ophthalmol20260
Retinal vasculature changes after 0.125% atropine treatment in children with myopia measured using optical coherence tomography angiography: A pilot study.
PMID 42877930 — pilot projects, pilots, retina, tomography, angiography, tomography, optical coherence, therapeutics, retinaldehyde, myopia, atropine, child
Taiwan J Ophthalmol20261
Topical versus oral antiviral therapy for cytomegalovirus anterior uveitis: a multicenter study in Taiwan.
PMID 42726112 — ophthalmology, uveitis, anterior, ganciclovir, cytomegalovirus, glaucoma, diagnosis, therapeutics, uveitis, antiviral agents, valganciclovir
Graefes Arch Clin Exp Ophthalmol20260
Retinopathy of prematurity epidemiology and treatment trend in a tertiary medical center in Taiwan: From 2016 to 2023.
PMID 42549255 — epidemiology, incidence, lasers, retinopathy of prematurity, therapeutics, infant
Taiwan J Ophthalmol20260
Epidemiology and treatment trends of retinopathy of prematurity: a multi-center study involving four Asian centers and one European center (2016-2023).
PMID 42397665 — epidemiology, vascular endothelial growth factor a, parturition, incidence, ophthalmology, multiple chronic conditions, birth weight, retinopathy of prematurity, therapeutics, demography, infant
Jpn J Ophthalmol20260

LeadR Networks

Main global connection map